Baseline characteristics of the 1149 patients recruited into the Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial-2 (RIGHT-2) randomized controlled trial

Abstract

Background

High blood pressure is common in acute stroke and associated with a worse functional outcome. Glyceryl trinitrate, a nitric oxide donor, lowers blood pressure in acute stroke and may improve outcome.

Aims

Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial-2 (RIGHT-2) tested the feasibility of performing a UK multicenter ambulance-based stroke trial, and the safety and efficacy of glyceryl trinitrate when administered by paramedics before hospital admission.

Methods

Paramedic-led ambulance-based multicenter prospective randomized single-blind blinded-endpoint parallel-group controlled trial of transdermal glyceryl trinitrate (given for four days) versus sham in patients with ultra-acute (<4 h) presumed stroke. Data are number (%), median (interquartile range) or mean (standard deviation).

Results

Recruitment ran from October 2015 to 31 May 2018. A total 1149 patients were recruited from eight UK ambulance services and taken to 54 acute hospitals. Baseline characteristics include: mean age 73 (15) years; female 555 (48%); median time from stroke to randomization 70 (45, 115) min; face-arm-speech scale score 2.6 (0.5); and blood pressure 162 (25)/92 (18) mmHg. The final diagnosis was ischemic stroke 52%, hemorrhagic stroke 13%, Transient Ischemic Attack (TIA) 9%, and mimic 25%. The main trial results will be presented in quarter 4 2018. The results will also be included in updated Cochrane systematic reviews, and individual patient data meta-analyses of all relevant randomized controlled trials.

Conclusion

It was feasible to perform a multicenter ambulance-based ultra-acute stroke trial in the UK and to treat with glyceryl trinitrate versus sham. The relatively unselected cohort of stroke patients is broadly representative of those admitted to hospital in the UK.

Trial registration

ISRCTN26986053.

Keywords

Acute stroke ambulance blood pressure glyceryl trinitrate nitric oxide pre-hospital randomized controlled trial

Get full access to this article

View all access options for this article.

References

Willmot

Bath

PMW

. The potential of nitric oxide therapeutics in stroke. Expert Opin Investig Drugs 2003; 12: 455–470.

Srivastava

Bath

Bayraktutan

. Current therapeutic strategies to mitigate the eNOS dysfunction in ischaemic stroke. Cell Mol Neurobiol 2012; 32: 319–336.

Garry

Ezra

Rowland

Westbrook

Pattinson

. The role of the nitric oxide pathway in brain injury and its treatment – from bench to bedside. Exp Neurol 2015; 263: 235–243.

Willmot

Murphy

Leonardi-Bee

Bath

. Systematic review of nitric oxide donors and L-arginine in experimental stroke: effects on infarct size and cerebral blood flow. Cerebrovasc Dis 2003; 16: S3 66,(abstract).

Maniskas

Roberts

Trueman

et al.

Intra-arterial nitroglycerin as directed acute treatment in experimental ischemic stroke. J Neurointerv Surg 2018; 10: 29–33.

Butterworth

Cluckie

Jackson

SHD

Buxton-Thomas

Bath

PMW

. Pathophysiological assessment of nitric oxide (given as sodium nitroprusside) in acute ischaemic stroke. Cerebrovasc Dis 1998; 8: 158–165.

Bath

PMW

Pathansali

Iddenden

Bath

. The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and platelet function in acute stroke. Cerebrovasc Dis 2001; 11: 265–272.

Rashid

Weaver

Leonardi-Bee

Fletcher

Bath

PMW

. The effects of transdermal glyceryl trinitrate, a nitric oxide donor on blood pressure, cerebral and cardiac haemodynamics and plasma nitric oxide levels in acute stroke. J Stroke Cerebrovasc Dis 2003; 13: 143–151.

Willmot

Ghadami

Whysall

Clarke

Wardlaw

Bath

. Transdermal glyceryl trinitrate lowers blood pressure and maintains cerebral blood flow in recent stroke. Hypertension 2006; 47: 1209–1215.

10.

Ankolekar

Fuller

Cross

et al.

Feasibility of an ambulance-based stroke trial, and safety of glyceryl trinitrate in ultra-acute stroke: the Rapid Intervention with Glyceryl Trinitrate in Hypertensive Stroke Trial (RIGHT, ISRCTN66434824). Stroke 2013; 44: 3120–3128.

11.

Bath

Woodhouse

Scutt

et al.

Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial-factorial randomised controlled trial. Lancet 2015; 385: 617–628.

12.

Woodhouse

Scutt

Krishnan

et al.

Effect of hyperacute administration (within 6 h) of transdermal glyceryl trinitrate, a nitric oxide donor, on outcome after stroke: subgroup analysis of the Efficacy of Nitric Oxide in Stroke (ENOS) Trial. Stroke 2015; 46: 3194–3201.

13.

Bath

Woodhouse

Krishnan

et al.

Effect of treatment delay, stroke type, and thrombolysis on the effect of glyceryl trinitrate, a nitric oxide donor, on outcome after acute stroke: a systematic review and meta-analysis of individual patient from randomised trials. Stroke Res Treat 2016; 2016: 9706720.

14.

Leonardi-Bee

Bath

PMW

Phillips

Sandercock

PAG

. for the IST Collaborative Group. Blood pressure and clinical outcomes in the International Stroke Trial. Stroke 2002; 33: 1315–1320.

15.

Willmot

Leonardi-Bee

Bath

. High blood pressure in acute stroke and subsequent outcome: a systematic review. Hypertension 2004; 43: 18–24.

16.

Sprigg

Gray

Bath

et al.

Relationship between outcome and baseline blood pressure and other haemodynamic measures in acute ischaemic stroke: data from the TAIST trial. J Hypertens 2006; 24: 1413–1417.

17.

Geeganage

Tracy

England

et al.

Relationship between baseline blood pressure parameters (including mean pressure, pulse pressure, and variability) and early outcome after stroke: data from the Tinzaparin in Acute Ischaemic Stroke Trial (TAIST). Stroke 2011; 42: 491–493.

18.

Appleton

Scutt

Dixon

et al.

Ambulance-delivered transdermal glyceryl trinitrate versus sham for ultra-acute stroke: rationale, design and protocol for the Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial-2 (RIGHT-2) trial (ISRCTN26986053). Int J Stroke 2017, pp. 1747493017724627.

19.

Scutt

Appleton

Dixon

et al.

Statistical analysis plan for the ‘Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial-2 (RIGHT-2)’. Eur Stroke J 2018; 3: 193–196.

20.

Bamford

Sandercock

Dennis

Burn

Warlow

. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991; 337: 1521–1526.

21.

Sandset

Sanossian

Woodhouse

et al.

Protocol for a prospective collaborative systematic review and meta-analysis of individual patient data from randomized controlled trials of vasoactive drugs in acute stroke: The Blood pressure in Acute Stroke Collaboration, stage-3. Int J Stroke 2018; 13: 759–765.

22.

Ali

Bath

Brady

et al.

Development, expansion, and use of a stroke clinical trials resource for novel exploratory analyses. Int J Stroke 2012; 7: 133–138.

23.

Sandercock

Niewada

Czlonkowska

. The International Stroke Trial database. Trials 2011; 12: 101.

24.

Wardlaw

Bath

Sandercock

et al.

The NeuroGrid stroke examplar clinical trial protocol. Int J Stroke 2007; 2: 63–69.

25.

Bath

Krishnan

. Interventions for deliberately altering blood pressure in acute stroke. Cochrane Database Syst Rev 2014; 10: Cd000039.

26.

Bath

Krishnan

Appleton

. Nitric oxide donors (nitrates), L-arginine, or nitric oxide synthase inhibitors for acute stroke. Cochrane Database Syst Rev 2017; 4: Cd000398.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.28 MB